methamphetamine has been researched along with AIDS-Associated Nephropathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, J; Hu, X; Li, J; Li, Z; Yang, G; Zeng, B; Zeng, X; Zhang, D | 1 |
Ake, C; Kaul, M; Maung, R; Roberts, AJ; Sejbuk, NE | 1 |
2 other study(ies) available for methamphetamine and AIDS-Associated Nephropathy
Article | Year |
---|---|
Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
Topics: AIDS-Associated Nephropathy; Animals; Blood-Brain Barrier; Ginsenosides; Glutathione; Male; Methamphetamine; Oxidative Stress; Permeability; Phytotherapy; Rats, Sprague-Dawley; Superoxide Dismutase; tat Gene Products, Human Immunodeficiency Virus | 2018 |
Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.
Topics: AIDS-Associated Nephropathy; Analysis of Variance; Animals; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Female; HIV Envelope Protein gp120; HIV-1; Male; Methamphetamine; Mice; Mice, Transgenic; Motor Activity; Stereotyped Behavior | 2010 |